logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea

Boum Y II, Juan-Giner A, Hitchings MD, Soumah A, Strecker T,  et al.
2020-06-01 • Vaccine
2020-06-01 • Vaccine
Background
As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional inf...
Journal Article
|
Short Report

Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection

Wanda F, Nkemenang P, Ehounou G, Tchaton M, Comte E,  et al.
2014-07-30 • BMC Infectious Diseases
2014-07-30 • BMC Infectious Diseases
In West and Central Africa Buruli ulcer (BU) and HIV co-infection is increasingly recognised and management of these two diseases combined is an emerging challenge for which there is lit...
Journal Article
|
Research

Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea

Juan-Giner A, Tchaton M, Jemmy J-P, Soumah A, Boum Y II,  et al.
2018-09-25 • Vaccine
2018-09-25 • Vaccine
As part of the ring vaccination trial in Guinea, Front Line Workers were invited to participate in a sub-study to provide additional information on the immunogenicity and safety of rVSVΔ...